Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib was effective in treating both early and late onset alopecia areata.

ILC1-like cells can independently cause alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Human keratinocytes do not naturally respond to androgens.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

CTIP2 may help in skin development and maintenance.

Sheep have 17 keratin genes, similar to humans, but with different expression patterns affecting wool and hair.

Mutations in the ST14 gene cause skin and hair issues by disrupting important protein processing.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

RD26 controls root hair growth during drought by repressing key genes, helping plants save energy.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Androgen receptors help prostate cancer cells grow and resist drugs.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

HB24 helps convert IBA to IAA, promoting root hair growth.

Type I keratin genes are closely linked to the rex locus on mouse chromosome 11, affecting hair development.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.